PTN Palatin Technologies, Inc.

AMEX
$6.13

Palatin Technologies, Inc. (PTN) is confirmed to report earnings on November 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.32 per share.

Palatin Technologies Missed Consensus Estimates
Tuesday, November 17, 2026 · 7:30 AM ET
Earnings Date
1st Quarter, Sep 2026
Nov 17
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs ($0.32)
Rev est $3.93M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Palatin Technologies, Inc.

Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Sector

Healthcare

Industry

Diagnostic Substances

Charts powered in part by Lightweight Charts™ by TradingView.